PCNU in the treatment of recurrent medulloblastoma and ependymoma -A POG study

Abdelsalam H. Ragab; Peter Burger; Solomon Badnitsky; Jeffrey Krischer; Jan Van Eys

doi:10.1007/BF00165583

PCNU in the treatment of recurrent medulloblastoma and ependymoma -A POG study

Abdelsalam H. Ragab, Peter Burger, Solomon Badnitsky, Jeffrey Krischer, Jan Van Eys

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m²) in a Phase 11 trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.

Original language	English (US)
Pages (from-to)	341-342
Number of pages	2
Journal	Journal of neuro-oncology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1007/BF00165583
State	Published - Dec 1986
Externally published	Yes

ASJC Scopus subject areas

Oncology
Neurology
Clinical Neurology
Cancer Research

Access to Document

10.1007/BF00165583

Cite this

@article{b5939b3b6a4c45eda3d40de35d4fae02,

title = "PCNU in the treatment of recurrent medulloblastoma and ependymoma -A POG study",

abstract = "Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase 11 trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.",

author = "Ragab, {Abdelsalam H.} and Peter Burger and Solomon Badnitsky and Jeffrey Krischer and {Van Eys}, Jan",

year = "1986",

month = dec,

doi = "10.1007/BF00165583",

language = "English (US)",

volume = "3",

pages = "341--342",

journal = "Journal of neuro-oncology",

issn = "0167-594X",

publisher = "Kluwer Academic Publishers",

number = "4",

}

TY - JOUR

T1 - PCNU in the treatment of recurrent medulloblastoma and ependymoma -A POG study

AU - Ragab, Abdelsalam H.

AU - Burger, Peter

AU - Badnitsky, Solomon

AU - Krischer, Jeffrey

AU - Van Eys, Jan

PY - 1986/12

Y1 - 1986/12

N2 - Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase 11 trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.

AB - Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase 11 trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=0022588431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022588431&partnerID=8YFLogxK

U2 - 10.1007/BF00165583

DO - 10.1007/BF00165583

M3 - Article

C2 - 3958779

AN - SCOPUS:0022588431

SN - 0167-594X

VL - 3

SP - 341

EP - 342

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

IS - 4

ER -

PCNU in the treatment of recurrent medulloblastoma and ependymoma -A POG study

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this